Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in ZIKV Infected Patients

Condition:   Treatment of Acute Zika Virus Infection Interventions:   Biological: Tyzivumab;   Other: Placebo Sponsors:   Tychan Pte Ltd.;   Singapore Clinical Research Institute;   Duke-NUS Graduate Medical School Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Zika Virus